The Medical Journal of Australia

Episode 603: Who's eligible for GLP1 in Australia?

The Medical Journal of Australia

Show Notes

My name is Sally Block, the MJA’s news and online editor.

“The MJA acknowledges the Traditional Owners and Custodians of the land on which we live and work across Australia. This podcast was recorded on the lands of the Wangal people. I pay my respects to their Elders past and present.”

With the proliferation of GLP 1s globally, a new study published in the MJA aims to provide an estimate of the number of adults eligible for TGA approved medicine for chronic weight management.

At least four in ten adults are eligible for the drug and hundreds of thousands are eligible for the treatment of secondary prevention of heart disease.

Co-author and PhD candidate Jasmin Castrillon joins me now.

More from The Medical Journal of Australia

Oct 20, 2026

Osteoporosis is frequently known as a silent disease because symptoms often don’t show up until there’s a bone fracture.

Aug 24, 2026

Emergency laparotomies are performed on thousands of Australians each year for critical conditions like bowel obstruction and peritonitis. It’s a high-risk procedure with a mortality rate of 6.9%.

Aug 2, 2026

My name is Sally Block, the MJA’s news and online editor.

Jul 19, 2026

This week we look at improving the health of children and young Aboriginal and Torres Strait Islander peoples through participation.

Jul 7, 2026

This week is NAIDOC week and the MJA is publishing a special collection of articles that are Indigenous led and authored.

See all episodes →